Many patients who could benefit from home dialysis are receiving care in dialysis centers

(Press-News.org) Washington, DC (April 24, 2014) — Many kidney failure patients in Australia who could benefit from undergoing dialysis at home are being treated in hospitals and dialysis units, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). This is creating significant costs for healthcare providers and causing unnecessary disruptions to patients' lives.

Home dialysis is more convenient for patients and can provide similar or better care than hemodialysis, which must be done in a clinic. Blair Grace, PhD (Australia and New Zealand Dialysis and Transplant Registry) led a team that investigated the links between socio-economic status and use of home dialysis (which includes peritoneal dialysis and home hemodialysis) in Australia, a country with universal access to healthcare.

The researchers analyzed 23,281 adult patients who started dialysis in Australia between 2000 and 2011. Among the major findings: Patients from the most advantaged areas were 37% less likely to commence peritoneal dialysis and 19% more likely to use in-center hemodialysis than patients from the most disadvantaged areas. Socioeconomic status was not associated with use of home hemodialysis. Rural areas were more disadvantaged and had higher rates of peritoneal dialysis, while privately funded hospitals rarely used home dialysis. Patients from the most advantaged areas were nearly 6-times more likely to use private hospitals than those from the most disadvantaged areas.

"We expected to find that patients with more education and financial resources were more likely to use peritoneal dialysis and home hemodialysis, as has been demonstrated in other countries," said Dr. Grace. "Instead, we found that patients from socio-economically advantaged areas were less likely to use peritoneal dialysis and more likely to use in-center hemodialysis." He noted that any non-medical factors—such as socioeconomic status—that reduce the numbers of patients receiving home dialysis are likely costing healthcare providers and disrupting patients' lives unnecessarily.

It's unclear why private hospitals in Australia rarely use home dialysis, and why patients from advantaged areas are more likely to use private hospitals. "More research is required to determine if patients from advantaged areas choose private hospitals knowing they want to dialyze in center, or whether they attend public hospitals then get directed towards in-center dialysis," Dr. Grace explained.

In an accompanying editorial, Gihad Nesrallah, MD (St. Michael's Hospital, in Ontario) and Braden Manns, MD (University of Calgary, in Alberta) stressed that socioeconomic factors and their correlates represent only one of many factors that have an impact on which type of dialysis a patient receives. They noted that "until new comparative effectiveness research and guidelines are available, policy makers and providers would do well to ensure that above all else, patients are given the opportunity to make informed decisions."

INFORMATION: Highlights In Australia, kidney failure patients from the most advantaged areas were less likely to use home dialysis and more likely to use in-center hemodialysis than patients from the most disadvantaged areas. Patients from the most advantaged areas were more likely to use private hospitals than those from the most disadvantaged areas.

Approximately 2 million kidney disease patients in the world receive some sort of dialysis treatment.

Study co-authors include Philip Clayton, MB BS, FRACP, PhD, Nicholas Gray, MBBS, FRACP, and Stephen McDonald MBBS(Hons), PhD, FRACP.

Disclosures: The authors reported no financial disclosures.

The article, entitled "Socio-Economic Differences in the Uptake of Home Dialysis," will appear online at http://cjasn.asnjournals.org/ on April 24, 2014.

The editorial, entitled "Do Socioeconomic Factors Impact Dialysis Modality Selection?" will appear online at http://cjasn.asnjournals.org/ on April 24, 2014.

The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.

Founded in 1966, and with more than 14,000 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.